URGN

UroGen Pharma Ltd.

-$218.5M

Net Activity

Institutions Holding

173

Popularity Rank

#3244

Avg Weight

0.21%

Total Value

$841.8M

Ownership Trend

173 institutions currently hold URGN, with 80 net buyers and 77 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

77

Net Buying Institutions

80

Key Holders

View all 173 holding institutions

Quarterly Activity

Recent Activity

+$446.7M

Total Buy Value

$454.4M

Total Sell Value

New buy28
Trim50
Add52
Sold out27

80

Net Buyers

77

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

3

Filings (90d)

$890K

Total Est. Value

25K shares

Planned Shares

Last Filed 2026-07-09
FilerFiling DateEst. Value
Schoenberg Mark2026-07-09$400K
Schoenberg Mark2026-06-22$350K
Schoenberg Mark2026-06-09$140K

Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding UroGen Pharma Ltd. (URGN)?
Major stakeholders currently include Rtw Investments, LP ($81.7M), BlackRock, Inc. ($51.2M), Toronto Dominion Bank ($47.0M). Based on the latest 13F filings, there are a total of 173 tracked investment funds and institutions maintaining positions in URGN.
What is the overall institutional sentiment toward URGN recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $218.5M, driven by 80 managers accumulating shares while 77 reduced their exposure.
Which institutions have been selling or reducing their URGN positions?
In the latest period, 50 funds trimmed their holdings, and 27 managers completely exited their positions. The aggregate reported sell value was $454.4M.
Are there any notable investors adding URGN to their portfolios?
Yes, buying activity remains notable. 28 institutions opened new positions in {ticker}, and 52 existing holders added to their shares. The total reported buy value for the quarter amounted to $446.7M.

Related Stocks